< Radiation Oncology < Bladder
|
- RTOG Website
- Wikibooks list of RTOG trials
Number | Title |
09-26 | A Phase II Protocol For Patients With Stage T1 Bladder Cancer To Evaluate Selective Bladder Preserving Treatment By Radiation Therapy Concurrent With Cisplatin Chemotherapy Following a Thorough Transurethral Surgical Re-Staging |
07-12 | A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy |
05-24 | A Phase I/II Trial Of A Combination Of Paclitaxel And Trastuzumab With Daily Irradiation Or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery For Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer |
Number | Title | Publication |
02-33 | A Phase II Randomized Trial For Patients With Muscle-Invading Bladder Cancer Evaluating Transurethral Surgery And BID Irradiation Plus Either Paclitaxel And Cisplatin Or 5-Fluorouracil And Cisplatin Followed By Selective Bladder Preservation And Gemcitabine/Paclitaxel/Cisplatin Adjuvant Chemotherapy | |
99-06 | A Phase I/II Trial In Patients With Muscle-Invading Bladder Cancer Of Transurethral Surgery Plus Taxol, Cisplatin, And BID Irradiation Followed By Either Selective Bladder Preservation Or Radical Cystectomy And Adjuvant Chemotherapy | PMID 19100600 |
97-06 | A Phase I/II Trial In Operable Patients With Muscle-Invading Bladder Cancer Of Transurethral Surgery And Cisplatinum/ BID Irradiation Followed by Either Selective Bladder Preservation Or Radical Cystectomy And Adjuvant Chemotherapy | PMID 14529770 |
95-06 | A Phase I/II Trial Of Transurethral Surgery Plus Induction Chemoradiotherapy Followed By Either Selective Bladder Preservation Or Radical Cystectomy As Determined By Initial Response And Operability In Patients With Muscle-Invading Bladder Cancer | PMID 11110598 |
91-16 | Pilot Study of the Quality of Life of Bladder Cancer Patients Being Treated on the Companion Protocol RTOG-8903 | |
89-03 | A Phase III Trial To Study The Role of Neoadjuvant MCV Chemotherapy Combined With Transurethral Surgery Plus Cisplatin With Radiation Therapy For Selective Bladder Preservation In Patients With Muscle-Invading Bladder Cancer | PMID 9817278 |
88-14 | Phase I/II Study of Neoadjuvant Chemotherapy with MCV (MTX/CDDP/VBL) with Intraoperative Electron Beam Radiotherapy and Pre- and Postoperative External Beam Radiotherapy in Patients with Invasive Bladder Carcinoma | |
88-02 | Phase I/II Study of Neoadjuvant Combined Modality Treatment with Chemotherapy with MCV (MTX/DDP/VBL) plus Radiotherapy and DDP with Selective Bladder Preservation in Patients with Invasive Bladder Cancer | PMID 8558186 |
87-05 | Phase I/II Study of Radiotherapy and Hyperthermia in Patients with Selected Measurable Superficial Tumors | PMID 8256760 |
87-03 | Phase I/II Study of Combined Modality Therapy with DDP and Regional Hyperthermia in Patients with Malignancies of the Pelvis and Lower Abdomen | |
86-08 | Phase II Trial of WR-2721 Administered Before Protracted Fractionated Radiotherapy in Patients with Cancer of the Rectum, Cervix, or Bladder | |
85-12 | Phase II Study of Radiotherapy plus Chemotherapy with cis-Platinum for Stage B/C/D1 Carcinoma of the Bladder with Surgery for Treatment Failures | PMID 8478228 |
83-08 | Phase I/II Evaluation of Twice-Daily Fractional Radiotherapy for Locally Advanced Stage B/C/D Transitional Cell and Unresectable Squamous Cell Carcinoma of the Bladder | PMID 3058657 |
81-10 | Phase III Photon vs Mixed Beam Preoperative Radiotherapy for Stage B/C/D Carcinoma of the Bladder | |
81-06 | Phase III Randomized Comparison of Sandwich vs Standard Preoperative Adjuvant Radiotherapy in Stage B/C Bladder Cancer | |
81-05 | Phase I/II Misonidazole and Radiotherapy for Inoperable Bladder Cancer | |
78-26 | Photon Radiotherapy vs Pion Radiotherapy for Transitional Cell Carcinoma of the Urinary Bladder | |
78-21 | Phase I/II Radiosensitization with Misonidazole plus Radiotherapy for Bladder Cancer | PMID 7180834 |
78-17 | Phase II Study of Misonidazole plus Intraoperative Radiotherapy for Nonresectable Carcinomas | |
78-16 | Phase I-II Hyperthermia (43.5 Degrees Centigrade) Before and After Radiation Treatment for Human Tumors | |
78-04 | Adjuvant Radiotherapy before and after Surgery for Bladder Cancer | PMID 3967204 |
77-05 | Radiotherapy with Neutrons Alone or with Photons with or without Surgery for Urinary Bladder Cancer | PMID 6375854 |
76-12 | Preoperative or Postoperative Radiotherapy or Radiotherapy Alone for Clinical Stage B1 or B2 or C Bladder Carcinoma | |
71-04 | Comparison of Split-Course versus Continuous Radiotherapy for Carcinoma of the Head and Neck and Urogenital Regions | PMID 4050737 |
This article is issued from Wikibooks. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.